Ensysce Biosciences, Inc. (ENSC) Form S-3 — Jun 4, 2026
Ensysce Biosciences, Inc. (ENSC) filed an S-3 registration statement to register 1,300,000 shares of common stock for resale by selling security holders, including Galephar Pharmaceutical Research, Inc. and Hector Feliciano. The company will not receive any proceeds from these sales, which are tied to milestone payments and agreements.
Key figures
- Gross Proceeds
- 387010
- Offering Price
- 0.2977
- Shares Offered
- 1300000
- Shares Outstanding
- 15365530
- Floor Price
- 0.4104
- Last Reported Price
- 0.262
- Warrant Closing Bid
- 0.0062
- Additional Securities Commitment
- 16000000
- Recent Private Placement Proceeds
- 2000000
- Preferred Conversion Price Apr2026
- 0.55
- Preferred Conversion Price Nov2025
- 2.5
Price after filing
1 day: 0.0%7 days: -11.6%30 days: -4.8%
Close on the filing date to close N calendar days later (from $0.30). Historical, not a forecast.
AI analysis
Red flags6 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.